Who Supplies Anastrozole? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Anastrozole exports, with 158+ registered manufacturers shipping to buyers across 99+ countries — yet a handful of companies dominate the shipments. INTAS PHARMACEUTICALS LIMITED holds the largest share at 83.6% (export value: $92.6M). Close behind, EUGIA PHARMA SPECIALITIES LIMITED (2.6%, $2.9M). ZYDUS LIFESCIENCES LIMITED (2.3%, $2.5M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Anastrozole? Top Manufacturers & Their Buyers
Flow of Anastrozole from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Anastrozole Supplier Network — Key Market Intelligence
The Anastrozole export market from India is led by INTAS PHARMACEUTICALS LIMITED, which alone commands a 83.6% share, shipping $92.6M worth of product across 209 shipments. The second-largest exporter, EUGIA PHARMA SPECIALITIES LIMITED, contributes $2.9M (2.6%) to the overall market. Combined, the top two suppliers alone account for 86.2% of all Anastrozole exports, indicating a relatively concentrated supply base.
Across all 158 tracked manufacturers, the total Anastrozole export value stands at $110.7M from 2.2K shipments. The market average shipment value is $49.5K. The single largest buyer relationship in terms of trade value is EVERSANA LIFE SCIENCES SERVICES LLC, receiving $91.4M worth of product.
The combined buyer network spans 18 named purchasing companies, including EVERSANA LIFE SCIENCES SERVICES LLC, ACCORD HEALTHCARE INC., ACCORD UK, AUROBINDO PHARMA USA INC, AUROLOGISTICS LLC, (AUROBINDO PHARM and 13 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1INTAS PHARMACEUTICALS LIMITED
INTAS PHARMACEUTICALS LIMITED is the first-largest Anastrozole exporter from India, with a market share of 83.6% and a total export value of $92.6M across 209 shipments. Their average shipment value of $442.8K is above the market average of $49.5K, suggesting premium or bulk contract pricing.
INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. EVERSANA LIFE SCIENCES SERVICES LLC is the dominant customer, accounting for 98.8% of this supplier's tracked business. Top customers include:
• EVERSANA LIFE SCIENCES SERVICES LLC — $91.4M across 207 shipments (98.8% of this supplier's total exports)
• EVERSANA LIFE SCIENCES SERVICES LLC — $567.7K across 1 shipments (0.6% of this supplier's total exports)
• ACCORD HEALTHCARE INC. — $233.6K across 1 shipments (0.3% of this supplier's total exports)
• TO THE ORDER — $172.6K across 0 shipments (0.2% of this supplier's total exports)
• ACCORD UK — $131.7K across 0 shipments (0.1% of this supplier's total exports)
Key Insight: INTAS PHARMACEUTICALS LIMITED's per-shipment value of $442.8K is 795% above the market average of $49.5K, consistent with large-order contracts or value-added formulations.
2EUGIA PHARMA SPECIALITIES LIMITED
EUGIA PHARMA SPECIALITIES LIMITED is the second-largest Anastrozole exporter from India, with a market share of 2.6% and a total export value of $2.9M across 116 shipments. Their average shipment value of $25.1K is below the market average of $49.5K, reflecting a high-volume, competitive pricing strategy.
EUGIA PHARMA SPECIALITIES LIMITED serves 5 named buyers in our database. AUROBINDO PHARMA USA INC is the dominant customer, accounting for 52.8% of this supplier's tracked business. Top customers include:
• AUROBINDO PHARMA USA INC — $1.5M across 61 shipments (52.8% of this supplier's total exports)
• AUROBINDO PHARMA USA INC — $886.7K across 35 shipments (30.5% of this supplier's total exports)
• AUROLOGISTICS LLC, (AUROBINDO PHARM — $244.7K across 10 shipments (8.4% of this supplier's total exports)
• AUROBINDO PHARMA USA INC — $140.5K across 6 shipments (4.8% of this supplier's total exports)
• AUROLOGISTICS LLC, (AUROBINDO PHARM — $101.7K across 4 shipments (3.5% of this supplier's total exports)
Key Insight: EUGIA PHARMA SPECIALITIES LIMITED operates with high shipment frequency (116 shipments) at a per-shipment value of $25.1K, indicating a broad distribution network with many smaller, regular orders.
3ZYDUS LIFESCIENCES LIMITED
ZYDUS LIFESCIENCES LIMITED is the third-largest Anastrozole exporter from India, with a market share of 2.3% and a total export value of $2.5M across 111 shipments. Their average shipment value of $22.9K is below the market average of $49.5K, reflecting a high-volume, competitive pricing strategy.
ZYDUS LIFESCIENCES LIMITED serves 5 named buyers in our database. EVERSANA LIFE SCIENCES SERVICES LLC is the dominant customer, accounting for 82.0% of this supplier's tracked business. Top customers include:
• EVERSANA LIFE SCIENCES SERVICES LLC — $2.1M across 91 shipments (82.0% of this supplier's total exports)
• AMERISOURCE HEALTH SERVICES — $338.7K across 15 shipments (13.3% of this supplier's total exports)
• AMERISOURCE HEALTH SERVICES — $45.8K across 2 shipments (1.8% of this supplier's total exports)
• ZYDUS PHARMACEUTICAL — $36.9K across 2 shipments (1.5% of this supplier's total exports)
• ZYDUS PHARMACEUTICAL — $36.0K across 2 shipments (1.4% of this supplier's total exports)
Key Insight: ZYDUS LIFESCIENCES LIMITED operates with high shipment frequency (111 shipments) at a per-shipment value of $22.9K, indicating a broad distribution network with many smaller, regular orders.
4NATCO PHARMA LIMITED
NATCO PHARMA LIMITED is the fourth-largest Anastrozole exporter from India, with a market share of 2.1% and a total export value of $2.3M across 68 shipments. Their average shipment value of $33.7K is below the market average of $49.5K, reflecting a high-volume, competitive pricing strategy.
NATCO PHARMA LIMITED serves 5 named buyers in our database. BRECKENRIDGE PHARMACEUTICAL INC is the dominant customer, accounting for 57.5% of this supplier's tracked business. Top customers include:
• BRECKENRIDGE PHARMACEUTICAL INC — $1.3M across 39 shipments (57.5% of this supplier's total exports)
• XXECKXXRIDXX PHXXMAC — $429.3K across 13 shipments (18.7% of this supplier's total exports)
• LEXON UK LIMITED — $275.0K across 8 shipments (12.0% of this supplier's total exports)
• MARCAN PHARMACEUTICALS INC — $215.0K across 6 shipments (9.4% of this supplier's total exports)
• LEXON UK LIMITED — $54.1K across 2 shipments (2.4% of this supplier's total exports)
Key Insight: NATCO PHARMA LIMITED operates with high shipment frequency (68 shipments) at a per-shipment value of $33.7K, indicating a broad distribution network with many smaller, regular orders.
5JODAS EXPOIM PRIVATE LIMITED
JODAS EXPOIM PRIVATE LIMITED is the fifth-largest Anastrozole exporter from India, with a market share of 1.7% and a total export value of $1.9M across 24 shipments. Their average shipment value of $77.9K is above the market average of $49.5K, suggesting premium or bulk contract pricing.
JODAS EXPOIM PRIVATE LIMITED serves 5 named buyers in our database. OOO JODAS EXPOIM is the dominant customer, accounting for 74.1% of this supplier's tracked business. Top customers include:
• OOO JODAS EXPOIM — $1.4M across 18 shipments (74.1% of this supplier's total exports)
• M/S. OOO JODAS EXPOI — $310.9K across 4 shipments (16.6% of this supplier's total exports)
• OOO JODAS EXPOIM — $131.6K across 2 shipments (7.0% of this supplier's total exports)
• SOFTCARE INTERNATION — $28.6K across 0 shipments (1.5% of this supplier's total exports)
• SOFTCARE INTERNATION — $13.3K across 0 shipments (0.7% of this supplier's total exports)
Key Insight: JODAS EXPOIM PRIVATE LIMITED's per-shipment value of $77.9K is 58% above the market average of $49.5K, consistent with large-order contracts or value-added formulations.
6SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the fifth-largest Anastrozole exporter from India, with a market share of 0.9% and a total export value of $1.0M across 70 shipments. Their average shipment value of $15.0K is below the market average of $49.5K, reflecting a high-volume, competitive pricing strategy.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• M/S. SUN FARMACEUTICA DO BRAZIL LTD — $400.9K across 27 shipments (38.3% of this supplier's total exports)
• SUN FARMACEUTICA DO BRASIL LTDA — $196.5K across 13 shipments (18.8% of this supplier's total exports)
• SUN PHARMA PHILIPPIN — $178.0K across 12 shipments (17.0% of this supplier's total exports)
• SUN FARMACEUTICA DO BRASIL LTDA — $160.0K across 11 shipments (15.3% of this supplier's total exports)
• YUSEN LOGISTICS BENELUX BELGIUM — $111.7K across 7 shipments (10.7% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED operates with high shipment frequency (70 shipments) at a per-shipment value of $15.0K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Anastrozole Flows
Once Anastrozole leaves the manufacturing plants of companies like INTAS PHARMACEUTICALS LIMITED and EUGIA PHARMA SPECIALITIES LIMITED, it travels to 5 destination markets with a combined import value of $110.7M. United States absorbs the largest share at 92.3% ($102.2M), followed by Brazil (1.9%) and Russia (1.7%).
In United States — the top destination — named importers include EVERSANA LIFE SCIENCES SERVICES,LLC, EVERSANA LIFE SCIENCE SERVICES, AUROBINDO PHARMA USA., INC,. In Brazil, key buyers are M/S. SUN FARMACEUTICA DO BRAZIL LTD, SUN FARMACEUTICA DO BRASIL LTDA RUA, SUN FARMACEUTICA DO BRAZIL LTDA.
This geographic spread reflects Anastrozole's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Anastrozole Go? Top Importing Countries & Their Buyers
Trade flow of Anastrozole exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Anastrozole imports from India, with a total trade value of $102.2M across 234 shipments — representing a 92.3% share of all Anastrozole exports. The average shipment value of $436.6K is above the global average of $49.5K, indicating high-value procurement contracts or branded formulations. This market is served by 8 tracked buyers.
Named Anastrozole importers in United States: EVERSANA LIFE SCIENCES SERVICES,LLC is the largest buyer, accounting for 90.3% ($92.2M) of this market's total imports.
• EVERSANA LIFE SCIENCES SERVICES,LLC — $92.2M (90.3% of United States's total)
• EVERSANA LIFE SCIENCE SERVICES — $3.7M (3.6% of United States's total)
• AUROBINDO PHARMA USA., INC, — $1.6M (1.6% of United States's total)
Key Insight: United States's per-shipment average of $436.6K (782% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Anastrozole imports from India.
2Brazil
Brazil ranks as the second-largest destination for Anastrozole imports from India, with a total trade value of $2.1M across 30 shipments — representing a 1.9% share of all Anastrozole exports. The average shipment value of $70.5K is above the global average of $49.5K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.
Named Anastrozole importers in Brazil: M/S. SUN FARMACEUTICA DO BRAZIL LTD is the largest buyer, accounting for 27.8% ($587.3K) of this market's total imports.
• M/S. SUN FARMACEUTICA DO BRAZIL LTD — $587.3K (27.8% of Brazil's total)
• SUN FARMACEUTICA DO BRASIL LTDA RUA — $360.1K (17.0% of Brazil's total)
• SUN FARMACEUTICA DO BRAZIL LTDA — $310.4K (14.7% of Brazil's total)
Key Insight: Brazil's per-shipment average of $70.5K (43% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Brazil is a key market for Anastrozole imports from India.
3Russia
Russia ranks as the third-largest destination for Anastrozole imports from India, with a total trade value of $1.8M across 4 shipments — representing a 1.7% share of all Anastrozole exports. The average shipment value of $457.1K is above the global average of $49.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Anastrozole importers in Russia: OOO JODAS EXPOIM is the largest buyer, accounting for 75.8% ($1.4M) of this market's total imports.
• OOO JODAS EXPOIM — $1.4M (75.8% of Russia's total)
Key Insight: Russia's per-shipment average of $457.1K (824% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Russia is a key market for Anastrozole imports from India.
4Canada
Canada ranks as the fourth-largest destination for Anastrozole imports from India, with a total trade value of $1.2M across 16 shipments — representing a 1.0% share of all Anastrozole exports. The average shipment value of $72.0K is above the global average of $49.5K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Anastrozole importers in Canada: MARCAN PHARMACEUTICALS INC is the largest buyer, accounting for 23.5% ($271.1K) of this market's total imports.
• MARCAN PHARMACEUTICALS INC — $271.1K (23.5% of Canada's total)
• ACCORD HEALTHCARE INC. — $259.5K (22.5% of Canada's total)
Key Insight: Canada's per-shipment average of $72.0K (46% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Anastrozole imports from India.
5United Kingdom
United Kingdom ranks as the fifth-largest destination for Anastrozole imports from India, with a total trade value of $773.5K across 23 shipments — representing a 0.7% share of all Anastrozole exports. The average shipment value of $33.6K is below the global average of $49.5K, consistent with generic/API volume purchasing. This market is served by 2 tracked buyers.
Named Anastrozole importers in United Kingdom: LEXON UK LIMITED is the largest buyer, accounting for 35.5% ($275.0K) of this market's total imports.
• LEXON UK LIMITED — $275.0K (35.5% of United Kingdom's total)
• ACCORD UK — $246.6K (31.9% of United Kingdom's total)
Key Insight: United Kingdom receives frequent, smaller shipments of Anastrozole — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
United Kingdom is a key market for Anastrozole imports from India.
People Also Ask — Anastrozole Supplier & Trade Network
Who are the top suppliers of Anastrozole from India?+
Which companies buy Anastrozole from Indian manufacturers?+
Where does Anastrozole exported from India go?+
What is the market share of the top Anastrozole supplier from India?+
What is the average shipment value for Anastrozole exports from India?+
Is Anastrozole manufactured in India and exported globally?+
Which country imports the most Anastrozole from India?+
Who are the buyers of Anastrozole in Brazil?+
How concentrated is the Anastrozole supplier market in India?+
How do I find verified buyers for Anastrozole in specific countries?+
Anastrozole Trade Network — Key Takeaways
- 1INTAS PHARMACEUTICALS LIMITED is India's dominant Anastrozole exporter with a 83.6% market share and $92.6M in total exports — making it the single most important sourcing entity in this market.
- 2The top 158 suppliers collectively account for 93.2% of all tracked Anastrozole exports, with a combined trade value of $110.7M.
- 3United States is the largest destination market, absorbing 92.3% of India's Anastrozole exports ($102.2M). Brazil (1.9%) and Russia (1.7%) follow.
- 4With 2.2K total shipments averaging $49.5K each, the Anastrozole export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include EVERSANA LIFE SCIENCES SERVICES LLC, EVERSANA LIFE SCIENCES SERVICES LLC, AUROBINDO PHARMA USA INC, AUROBINDO PHARMA USA INC — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 99 countries
Network value: $110.7M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Anastrozole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Anastrozole.
- 2.Flow Mapping: 158 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,238 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 99 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,238 Verified Shipments
158 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists